Delivery Order 19AQMM23D0093-19AQMM24F2550
Award Date
9/30/24
Potential Completion Date
10/31/25
Potential Value
$2.5M
Funding Federal Agency
Bureau of Medical Services
Contracting Federal Agency
Office of Acquisition Management
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Columbia, MD 21046, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Office of Land and Emergency Management, a civilian agency, is for the procurement of AUTO-INJECTORS FOR NERVE AGENT EXPOSURE. The prime contractor is Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc. and a manufacturer of medical countermeasures, particularly autoinjector devices and nerve agent antidote treatments. The contract is a firm-fixed-price purchase order with a ceiling value of $27,529.20 and a completion date of May...
This federal contract award to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc., is for the development and delivery of an FDA-approved advanced autoinjector system (AAS). The definitive contract, valued at $41,936,532.62, is a cost-plus-incentive arrangement with the U.S. Department of Defense's Joint Program Executive Office for Chemical and Biological Defense. The award does not utilize a small business set-aside. Meridian, a manufacturer of medical countermeasures...
This $17,955,751.55 firm fixed-price delivery order was awarded to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc., by the Department of State Bureau of Medical Services. The contract is for the provision of autoinjectors and associated training devices to be delivered globally to Department of State personnel through September 2028 under the Department's "MANDRAKE 3.0 IDIQ" contract. This single-award IDIQ contract vehicle has a total potential value of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc. The contract is for $3,262,840.74 to provide 4522513207 ANTIDOTE TREATMENT products. Meridian Medical Technologies is a manufacturer of pharmaceutical products and medical devices, including nerve agent antidote treatments and autoinjector kits. This contract does not have a set-aside designation. Meridian has a...
This is a firm-fixed-price purchase order awarded by the U.S. Marshals Service Tactical Operations Division to Meridian Medical Technologies, LLC, a wholly-owned subsidiary of Pfizer Inc. The $15,514.80 contract is for the delivery of auto-injectors containing the nerve agent antidotes atropine and pralidoxime. The contract does not utilize any set-aside designations. Meridian Medical Technologies is a key provider of auto-injector devices and nerve agent antidote treatments across the federal...
This federal contract award is for the delivery of Epinephrine 0.3 mg auto-injectors to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Medical Supply Chain division of the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,260.76 and is a Firm Fixed Price Delivery Order with a completion date of July 16, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of epinephrine 0.3 mg auto-injectors to the Defense Logistics Agency (DLA) over a two-year period through June 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a wide range of...
The federal contract award is for the delivery of epinephrine 0.3 mg auto-injectors, with a ceiling value of $1,345.77. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). This is a delivery order contract with a firm fixed price pricing type and an ultimate completion date of October 28, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
This federal contract award is for the delivery of 4,565,069,710 units of epinephrine 0.3 mg auto-injectors over a two-year period ending on July 5, 2024. The contract was awarded to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA). The contract has a firm fixed-price ceiling of $1,150.20 and was awarded without the use of any set-aside designations. Amerisourcebergen also holds a $999,999,999.00 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Epinephrine 0.3 mg auto-injectors. The fixed-price delivery order, valued at $5,240.52, was awarded on June 9, 2022, with a completion date of June 10, 2022. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC,...